FAKTOR-OPTIONSSCHEIN - AMGEN | Market Closed - Boerse Frankfurt Warrants 01:15:37 15/06/2024 am IST | ||
| 0.45 EUR | 0.00% |
|
| Current month | -13.21% | ||
| 1 month | -29.23% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 14/24/14 | 0.46 | +2.22% |
| 13/24/13 | 0.45 | -4.26% |
| 12/24/12 | 0.47 | -2.08% |
| 11/24/11 | 0.48 | -7.69% |
| 10/24/10 | 0.52 | -3.70% |
Real-time Boerse Frankfurt Warrants
Last update June 15, 2024 at 01:15 am IST
More quotesStatic data
| Product type | Warrant Esotici e Strutturati |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SB01QY |
| ISIN | DE000SB01QY9 |
| Date issued | 09/06/2020 |
| Strike | 225.5 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.85 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 21.18 € |
|---|---|
| Lowest since issue | 0.19 € |
| Spread | 0.01 € |
| Spread % | 2.13% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
298.6
USD
Average target price
316.4
USD
Spread / Average Target
+5.97%
- Stock Market
- Certificates
- Certificat
